Dow Today: UnitedHealth Group (UNH) Lags
Holding back the Dow today is <b><a href="http://www.thestreet.com/quote/unh.html?cm_ven_int=tstwire">UnitedHealth Group</a></b> (NYSE:<a href="http://www.thestreet.com/quote/unh.html?cm_ven_int=tstwire">UNH</a>), which is lagging the broader Dow index with a $2.19 decline (-2.6%) bringing the stock to $80.76.
Naomi Hossain
Jul 31, 2014 10:00 AM EDT
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link
^DJI
) is trading down 122.0 points (-0.7%) at 16,758 as of Thursday, Jul 31, 2014, 9:36 a.m. ET. During this time, 18 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 302.6 million. The NYSE advances/declines ratio sits at 316 issues advancing vs. 2,500 declining with 164 unchanged.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Holding back the Dow today is
), which is lagging the broader Dow index with a $2.19 decline (-2.6%) bringing the stock to $80.76. This single loss is lowering the Dow Jones Industrial Average by 16.57 points or roughly accounting for 13.6% of the Dow's overall loss. Volume for UnitedHealth Group currently sits at 314,827 shares traded vs. an average daily trading volume of 3.6 million shares.
See our dividend calendar or top-yielding stocks list.
UnitedHealth Group has a market cap of $82.57 billion and is part of the health care sector and health services industry. Shares are up 10.2% year-to-date as of Wednesday's close. The stock's dividend yield sits at 1.8%.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States.
TheStreet Ratings rates UnitedHealth Group as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
You can view the full UnitedHealth Group Ratings Report.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more
Tax Preparation Checklist
By TurboTax
MSFTHDCMG
Microsoft Stock: Slow and Steady Leads to a $2 Trillion Market Cap (And Rising)
By Daniel Kline
NOBLPRDGX
Now's a Good Time for Considering Dividend Stocks